A Randomized Controlled Trial of Mindfulness Meditation Combined With BrainLink Intelligent Biofeedback Instrument on Pancreatic Cancer Patients Under Chemotherapy
2024

Mindfulness Meditation and Biofeedback for Pancreatic Cancer Patients

Sample size: 145 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mi Na, Zhang Shu‐Ting, Sun Xiao‐Li, Li Ting, Liao Yu, Dong Lei, Chu Ling‐Ling

Primary Institution: The Second Affiliated Hospital of Army Medical University

Hypothesis

Does mindfulness meditation combined with the BrainLink intelligent biofeedback instrument improve anxiety, pain, and quality of life in pancreatic cancer patients undergoing chemotherapy?

Conclusion

Mindfulness meditation combined with the BrainLink intelligent biofeedback instrument can significantly mitigate the anxiety, pain severity, and brain fatigue relief degree of pancreatic cancer patients under chemotherapy, thereby promoting their quality of life.

Supporting Evidence

  • Anxiety levels significantly decreased in the experimental group compared to the control group after 4, 8, and 12 weeks.
  • Pain severity was lower in the experimental group at all follow-up points.
  • Quality of life scores improved significantly in the experimental group compared to the control group.

Takeaway

This study shows that mindfulness meditation can help pancreatic cancer patients feel less anxious and in less pain while also making them feel better overall during chemotherapy.

Methodology

145 pancreatic cancer patients were randomly assigned to either a control group receiving routine care or an experimental group receiving mindfulness meditation combined with biofeedback, with assessments conducted at baseline and after 4, 8, and 12 weeks.

Potential Biases

Potential biases may arise from the single-center design and the subjective nature of some assessment scales.

Limitations

The study was conducted at a single hospital and had a relatively small sample size.

Participant Demographics

Patients aged 18 to 75, diagnosed with pancreatic cancer, undergoing chemotherapy.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/brb3.70197

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication